Want to join the conversation?
$XRX 2Q15 Q&A: Shannon from Cross Research asked about details on restructuring program? Bob replied, we are heavily focused on services rather than DocTech. We're trying to be little bit careful, but not too quickly relative to optimizing our cost base without being sure that we could maintain and continue to increase delivery qualities.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?